Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Ibrutinib-associated Pneumocystis jirovecii pneumonia.

× No keyword cloud information.

8 in total

1. Fungal immunology in clinical practice: Magical realism or practical reality?

Authors: Christina C Chang; Stuart M Levitz
Journal: Med Mycol Date: 2019-06-01 Impact factor: 4.076

Review 2. Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies.

Authors: Joshua S Davis; David Ferreira; Emma Paige; Craig Gedye; Michael Boyle
Journal: Clin Microbiol Rev Date: 2020-06-10 Impact factor: 26.132

Review 3. Cryptococcus neoformans empyema in a patient receiving ibrutinib for diffuse large B-cell lymphoma and a review of the literature.

Authors: Christopher David Swan; Thomas Gottlieb
Journal: BMJ Case Rep Date: 2018-07-18

4. Serious Infections in Patients Receiving Ibrutinib for Treatment of Lymphoid Cancer.

Authors: Tilly Varughese; Ying Taur; Nina Cohen; M Lia Palomba; Susan K Seo; Tobias M Hohl; Gil Redelman-Sidi
Journal: Clin Infect Dis Date: 2018-08-16 Impact factor: 9.079

5. Pneumocystis jirovecii pneumonia and institutional prophylaxis practices in CLL patients treated with BTK inhibitors.

Authors: Christine E Ryan; Matthew P Cheng; Nicolas C Issa; Jennifer R Brown; Matthew S Davids
Journal: Blood Adv Date: 2020-04-14

Review 6. Infections associated with immunotherapeutic and molecular targeted agents in hematology and oncology. A position paper by the European Conference on Infections in Leukemia (ECIL).

Authors: Georg Maschmeyer; Julien De Greef; Sibylle C Mellinghoff; Annamaria Nosari; Anne Thiebaut-Bertrand; Anne Bergeron; Tomas Franquet; Nicole M A Blijlevens; Johan A Maertens
Journal: Leukemia Date: 2019-01-30 Impact factor: 11.528

Review 7. Prevention Strategies to Minimize the Infection Risk Associated with Biologic and Targeted Immunomodulators.

Authors: Elaheh Kordzadeh-Kermani; Hossein Khalili; Iman Karimzadeh; Mohammadreza Salehi
Journal: Infect Drug Resist Date: 2020-02-18 Impact factor: 4.003

8. BTK Inhibition Impairs the Innate Response Against Fungal Infection in Patients With Chronic Lymphocytic Leukemia.

Authors: Stefania Fiorcari; Rossana Maffei; Daniela Vallerini; Lydia Scarfò; Patrizia Barozzi; Monica Maccaferri; Leonardo Potenza; Paolo Ghia; Mario Luppi; Roberto Marasca
Journal: Front Immunol Date: 2020-08-28 Impact factor: 7.561

8 in total